HMGB1 and COVID-19: So far, it is the first clinical study investigating the role of circulating inflammatory and nociceptive molecules such as HMGB1, NLRP3 inflammasome, IL-6, IL-10, angiotensin II, and ACE2 in COVID-19 headache.